Biologics – Cell and Gene Therapies – Next Generation Sequencing Expert Panel - Member
United States2d ago
Key details
- Location
- United States
- Work style
- Onsite
- Level
- Senior
- Job type
- Full-time
- Function
- Science & Research
- Focus area
- other
- Posted
- 2d ago
Skills
About the role
Who is USP
The U.S. Pharmacopeial Convention (USP) is an independent scientific organization that collaborates with the world’s top experts in health and science to develop quality standards for medicines, dietary supplements, and food ingredients. USP’s fundamental belief that Equity = Excellence manifests in our core value of Passion for Quality through our more than 1,100 talented professionals across five global locations to deliver the mission to strengthen the supply of safe, quality medicines and supplements worldwide.
Who are our Expert Volunteers?
A hallmark of USP’s standards is that they are determined by independent scientific experts. USP Expert Volunteers are selected based on their individual expertise and experience and use their best personal, professional, and scientific judgment to work collaboratively on setting standards. USP Expert Volunteers must agree to disclose conflicts of interest and to uphold standards of conduct that preserve the integrity of the standard setting process.
2025-2030 Focus Area: Develop an informational general chapter describing best practices for next-generation sequencing-based methods used in analytical control of biological drugs, vaccines, and cell and gene therapies.
The chapter will provide guidance on selecting fit-for-purpose sequencing technologies and implementing appropriate sample preparation, library preparation, sequencing, and bioinformatics workflows. It will address short- and long-read technologies, method qualification and validation, GMP implementation, and lifecycle management.
Detailed considerations for viral detection are outside the scope; however, high-level considerations for NGS implementation in viral safety applications may be discussed as relevant.
2025-2030 KEY ISSUES:
- Selecting workflows, performance requirements and extent of qualification or validation based on intended use (e.g., identity, sequence integrity, component ratio).
- Determining fit-to-purpose approaches to sample preparation, extraction, reverse transcription, amplification and library preparation.
- Using complementary methods to characterize low frequency variants, potential artifacts and structurally complex samples.
- Using modular approach to qualification and validation of NGS-based methods for qualitative, limit and quantitative tests.
- Establishing controls, system suitability and acceptance criteria.
- Implementing, transferring and maintaining methods throughout their lifecycle in a GMP environment.
Required Expertise: Expertise in one or more of the following:
- Collaborative drafting and technical review.
- NGS method development for characterization testing.
- Qualification or validation of NGS-based analytical methods.
- Implementation of NGS-based methods in a GMP environment.
- Short-read or long-read sequencing platforms.
- Bioinformatics workflows, sequence databases, and interpretation of NGS data.
- NGS-based testing of oligonucleotides, including sequence confirmation or impurity characterization.
- NGS-based testing of vaccines.
- NGS-based testing of cell banks, virus banks or cell-based therapies, including integration-sit analysis.
- NGS-based testing of genome-editing therapies, including off-target analysis. NGS-based testing of in vivo gene therapies, including DNA impurity and DNA integrity analysis.
Preferred Expertise: Experience developing scientific guidance, consensus standards or technical publications Multiple product modalities or sequencing applications Orthogonal sequencing platforms
How well do you match this job?
Free account needed to apply or save. It takes a minute, and we'll bring you right back to this job.